The Case For Implementing TransCelerate's Modernization Of Statistical Analysis Framework
By Lin Taft
As the life sciences industry modernizes across all aspects of the field — from electronic health record data to consumer wearables — it is crucial that statistical analytics of clinical trial data for delivering drugs efficiently and safely to patients keeps pace and steps into the modern era as well.
This is especially important now for the pharma industry to expand on the options of analytical tools. In this highly regulated field, it is critical to ensure that all these tools being used to analyze data as part of clinical trial evidence-gathering efforts can be relied upon to produce accurate and consistent results capable of supporting regulatory submissions.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.